4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-030304
Director sold 3,237 shares at an average $60.11 ($194,589)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2021-05-03 | Sale | −3,139 | $60.08 | $188,591 | 2,589,157 | D |
| Tessier-Lavigne Marc Director | 2021-05-03 | Sale | −98 | $61.20 | $5,998 | 2,589,059 | D |
| Open-market sales · 3,237 sh · avg $60.11 · $194,589 | |||||||
Loading xslF345X03/doc4.xml…